Ameloblastoma cell lines derived from different subtypes demonstrate distinct developmental patterns in a novel animal experimental model

Abstract Objective Ameloblastoma is a representative odontogenic tumor comprising several characteristic invasive forms, and its pathophysiology has not been sufficiently elucidated. A stable animal experimental model using immortalized cell lines is crucial to explain the factors causing differences among the subtypes of ameloblastoma, but this model has not yet been disclosed. In this study, a novel animal experimental model has been established, using immortalized human ameloblastoma-derived cell lines. Methodology Ameloblastoma cells suspended in Matrigel were subcutaneously transplanted into the heads of immunodeficient mice. Two immortalized human ameloblastoma cell lines were used: AM-1 cells derived from the plexiform type and AM-3 cells derived from the follicular type. The tissues were evaluated histologically 30, 60, and 90 days after transplantation. Results Tumor masses formed in all transplanted mice. In addition, the tumors formed in each group transplanted with different ameloblastoma cells were histologically distinct: the tumors in the group transplanted with AM-1 cells were similar to the plexiform type, and those in the group transplanted with AM-3-cells were similar to the follicular type. Conclusions A novel, stable animal experimental model of ameloblastoma was established using two cell lines derived from different subtypes of the tumor. This model can help clarify its pathophysiology and hasten the development of new ameloblastoma treatment strategies.

[1]  R. Horch,et al.  Adipose-derived mesenchymal stem cells formed acinar-like structure when stimulated with breast epithelial cells in three-dimensional culture , 2018, PloS one.

[2]  M. Gottfried,et al.  The effect of mesenchymal stem cells’ secretome on lung cancer progression is contingent on their origin: primary or metastatic niche , 2018, Laboratory Investigation.

[3]  John M. Wright,et al.  The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2017 (4th) Edition. , 2018, Turk patoloji dergisi.

[4]  M. Ueda,et al.  Fibroblasts promote the collective invasion of ameloblastoma tumor cells in a 3D coculture model , 2017, FEBS open bio.

[5]  Chaidan Intapa Analysis of Prevalence and Clinical Features of Ameloblastoma and its Histopathological Subtypes in Southeast Myanmar and Lower Northern Thailand Populations: A 13-Year Retrospective Study. , 2017, Journal of clinical and diagnostic research : JCDR.

[6]  T. Iseki,et al.  Differential expression of the epithelial mesenchymal transition factors Snail, Slug, Twist, TGF-β, and E-cadherin in ameloblastoma , 2017, Medical Molecular Morphology.

[7]  J. Parker,et al.  Ameloblastoma Phenotypes Reflected in Distinct Transcriptome Profiles , 2016, Scientific Reports.

[8]  A. Sklavounou,et al.  A comparative study of bone remodeling molecules expression in different types of jaw ameloblastoma. , 2015, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[9]  C. Gomes,et al.  Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours , 2015, Tumor Biology.

[10]  R. West,et al.  Identification of recurrent SMO and BRAF mutations in ameloblastomas , 2014, Nature Genetics.

[11]  T. Kiyono,et al.  A novel ameloblastoma cell line (AM-3) secretes MMP-9 in response to Wnt-3a and induces osteoclastogenesis. , 2013, Oral surgery, oral medicine, oral pathology and oral radiology.

[12]  E. Bloemena,et al.  Histopathology of ameloblastoma of the jaws; some critical observations based on a 40 years single institution experience , 2011, Medicina oral, patologia oral y cirugia bucal.

[13]  C. Pan,et al.  Tissue inhibitor of metalloproteinase-2 inhibits ameloblastoma growth in a new mouse xenograft disease model. , 2010, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[14]  Q. Tao,et al.  Inhibition of ameloblastoma invasion in vitro and in vivo by inhibitor of metalloproteinase-2 activity. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[15]  T. Kukita,et al.  Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone. , 2005, Oral oncology.

[16]  N. Nakamura,et al.  Comparison of long-term results between different approaches to ameloblastoma. , 2002, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[17]  M. Kay,et al.  Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses , 2000, Nature Medicine.

[18]  A. Taniguchi,et al.  Establishment of ameloblastoma cell line, AM-1. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[19]  John M. Wright,et al.  Lucas's pathology of tumors of the oral tissues , 1998 .

[20]  H. Philipsen,et al.  Ameloblastoma: biological profile of 3677 cases. , 1995, European journal of cancer. Part B, Oral oncology.

[21]  W. Yue,et al.  MCF-7 human breast carcinomas in nude mice as a model for evaluating aromatase inhibitors , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  E. Dabelsteen,et al.  Human odontogenic keratocyst transplants in nude mice. , 1982, Scandinavian journal of dental research.